Pérez, P.; MarÃn, M.Q.; Lázaro-FrÃas, A.; Sorzano, C.Ó.S.; Gómez, C.E.; Esteban, M.; GarcÃa-Arriaza, J.
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B. Vaccines 2020, 8, 70.
https://doi.org/10.3390/vaccines8010070
AMA Style
Pérez P, MarÃn MQ, Lázaro-FrÃas A, Sorzano CÓS, Gómez CE, Esteban M, GarcÃa-Arriaza J.
Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B. Vaccines. 2020; 8(1):70.
https://doi.org/10.3390/vaccines8010070
Chicago/Turabian Style
Pérez, Patricia, MarÃa Q. MarÃn, Adrián Lázaro-FrÃas, Carlos Óscar S. Sorzano, Carmen E. Gómez, Mariano Esteban, and Juan GarcÃa-Arriaza.
2020. "Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B" Vaccines 8, no. 1: 70.
https://doi.org/10.3390/vaccines8010070
APA Style
Pérez, P., MarÃn, M. Q., Lázaro-FrÃas, A., Sorzano, C. Ó. S., Gómez, C. E., Esteban, M., & GarcÃa-Arriaza, J.
(2020). Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B. Vaccines, 8(1), 70.
https://doi.org/10.3390/vaccines8010070